Inventor · disambiguated record
Anthony Hyman
Also filed as: HYMAN ANTHONY · HYMAN ANTHONY A
6 granted patents·3 pending applications·1 citations·filing 2001–2023
66Inventor score
Top patents by PatentIndex Score
9 records- 0160US10434077B2Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseasesMAX PLANCK GESELLSCHAFT·Filed 2015·Granted Oct 8, 2019·1 cites·12 claims
- 0253US2025347697A1Accurate Method for Generating a Phase Diagram of a PolymerMAX PLANCK GESELLSCHAFT·Filed 2023·Application pending·0 cites
- 0350US12422427B2Compounds for treatment of diseases and methods of screening thereforMAX PLANCK GESELLSCHAFT·Filed 2019·Granted Sep 23, 2025·0 cites·22 claims
- 0440US7479369B2Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseasesCENIX BIOSCIENCE GMBH·Filed 2004·Granted Jan 20, 2009·0 cites·3 claims
- 0540US7368248B2Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseasesCENIX BIOSCIENCE GMBH·Filed 2001·Granted May 6, 2008·0 cites·2 claims
- 0638US10182999B2Glycolic acid enhances sperm mobilityMAX PLANCK GESELLSCHAFT·Filed 2015·Granted Jan 22, 2019·0 cites·12 claims
- 0738US7648827B2Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseasesCENIX BIOSCIENCE GMBH·Filed 2004·Granted Jan 19, 2010·0 cites·2 claims
- 0833US2007042981A1Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseasesCENIX BIOSCIENCE GMBH·Filed 2004·Application pending·0 cites
- 0926US2005101773A1Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agentsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →